SCHEMBL1090002

SCHEMBL1090002

CCCCCCCCCCNN

nearest known ligand 0.56

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.56
EPHX1 P07099 7/20 0.55
TSHR P16473 3/20 0.53
ALDH1A1 P00352 2/20 0.53
THRB P10828 1/20 0.50
ADH1B P00325 1/20 0.48
ADH1C P00326 1/20 0.48
ADH1A P07327 1/20 0.48
ADH4 P08319 1/20 0.48
ADH7 P40394 1/20 0.48
DNM1 Q05193 6/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1794577 1.00
SCHEMBL1090322 1.00 ALOX15 (0.56) ALOX15EPHX1TSHRALDH1A1THRB
SCHEMBL19838215 1.00 ALOX15 (0.56) ALOX15EPHX1TSHRALDH1A1THRB
SCHEMBL18343676 1.00 ALOX15 (0.56) ALOX15EPHX1TSHRALDH1A1THRB
SCHEMBL1088479 1.00 ALOX15 (0.56) ALOX15EPHX1TSHRALDH1A1THRB
SCHEMBL2722803 1.00 ALOX15 (0.56) ALOX15EPHX1TSHRALDH1A1THRB
SCHEMBL2722279 1.00 ALOX15 (0.56) ALOX15EPHX1TSHRALDH1A1THRB
SCHEMBL1088995 1.00 ALOX15 (0.56) ALOX15EPHX1TSHRALDH1A1THRB
SCHEMBL2723551 1.00 ALOX15 (0.56) ALOX15EPHX1TSHRALDH1A1THRB
SCHEMBL34083 1.00 ALOX15 (0.56) ALOX15EPHX1TSHRALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116390938-A Exendin-4 analogues TXP制药股份有限公司 2023-07-04 CN claimed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US claimed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US claimed
EP-1370563-A1 MESOPOROUS ORGANIC-INORGANIC HYBRID MATERIALS FOR SEPARATING GASES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2003-12-17 EP claimed
WO-2002076991-A1 MESOPOROUS ORGANIC-INORGANIC HYBRID MATERIALS FOR SEPARATING GASES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2002-10-03 WO claimed
US-4322502-A FOAMING AN UNSATURATED POLYESTER DISSOLVED IN UNSATURATED MONOMER,A PEROXIDE, ORGANOMETALLIC PROMOTER, AND A HYDRAZINE OR HYDROAZONE UNIROYAL, INC. (US) 1982-03-30 US claimed
EP-0048050-A1 Simultaneous expansion and cure of polyester resin composition UNIROYAL, INC. (US) 1982-03-24 EP claimed
EP-4748513-A1 COMPOSITE COPPER PARTICLES, METHOD FOR PRODUCING SAME, AND USE OF SAME Ishihara Sangyo Kaisha, Ltd. (JP) 2026-05-27 EP disclosed
US-12589451-B2 Paste composition and semiconductor device KYOCERA CORPORATION (JP) 2026-03-31 US disclosed
US-12544830-B2 Method for producing silver particles, thermosetting resin composition, semiconductor device, and electrical and/or electronic components KYOCERA CORPORATION (JP) 2026-02-10 US disclosed
US-12539539-B2 Silver particles, method for producing silver particles, paste composition, semiconductor device, and electrical and/or electronic components KYOCERA CORPORATION (JP) 2026-02-03 US disclosed
EP-4635650-A1 PASTE COMPOSITION, SEMICONDUCTOR DEVICE AND METHOD FOR MANUFACTURING SAME, AND ELECTRONIC COMPONENT AND METHOD FOR MANUFACTURING SAME KYOCERA Corporation (JP) 2025-10-22 EP disclosed
US-20250214180-A1 OXIDE-CONTAINING PLATE-SHAPED COPPER PARTICLE, PASTE COMPOSITION, SEMICONDUCTOR DEVICE, ELECTRICAL COMPONENT AND ELECTRONIC COMPONENT KYOCERA CORPORATION (JP) 2025-07-03 US disclosed
US-4521325-A FUEL ADDITIVE OLIN CORPORATION (US) 1985-06-04 US disclosed
US-4322502-A FOAMING AN UNSATURATED POLYESTER DISSOLVED IN UNSATURATED MONOMER,A PEROXIDE, ORGANOMETALLIC PROMOTER, AND A HYDRAZINE OR HYDROAZONE UNIROYAL, INC. (US) 1982-03-30 US disclosed
EP-0048050-A1 Simultaneous expansion and cure of polyester resin composition UNIROYAL, INC. (US) 1982-03-24 EP disclosed
US-4268486-A REACTING WITH A HYDRAZINE COMPOUND AND SEPARATING TRIVALENT CHROMIUM COMPOUNDS OLIN CORPORATION (US) 1981-05-19 US disclosed
US-4065472-A TISSUE SPECIFICITY PFIZER INC. (US) 1977-12-27 US disclosed
US-3962113-A METHOD FOR ACCELERATING OXYGEN REMOVAL EMPLOYING AN AQUEOUS SOLUTION OF AN ALKYL HYDRAZINE OLIN CORPORATION (US) 1976-06-08 US disclosed
US-3903140-A Diazadodecane prostaglandin compounds ALZA CORP 1975-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12539539-B2 Silver particles, method for producing silver particles, paste composition, semiconductor device, and electrical and/or electronic components DNMT3A, RPA1, BET1 ALOX15 3516/4885EPHX1 1853/4885TSHR 2309/4885
US-12589451-B2 Paste composition and semiconductor device SEM1, REV1, VMA21 ALOX15 1959/4885EPHX1 2502/4885TSHR 3902/4885
US-12544830-B2 Method for producing silver particles, thermosetting resin composition, semiconductor device, and electrical and/or electronic components RPL37A, RPL39, RPL36A ALOX15 3166/4885EPHX1 2020/4885TSHR 2817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.